Trial Profile

Comparison of controlled-release nifedipine + standard-dose candesartan versus up-titrated candesartan in patients with hypertension.

Status: Completed

Phase of Trial: Phase III

Latest Information Update: 12 Nov 2016

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Candesartan cilexetil/nifedipine (Primary) ; Candesartan cilexetil; Nifedipine
Indications Essential hypertension
Focus Therapeutic Use
Acronyms NICE-Combi

Most Recent Events

29 Sep 2016 Results of subanalysis (the relationship between the change of urinary albumin excretion and the changes of serum uric acid) presented at the 26th Scientific Meeting of the International Society of Hypertension
05 Nov 2010 New trial record.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com